SIV VACCINES PROTECT INFANT RHESUS MACAQUES AGAINST ORAL SIVEXPOSURE

SIV 疫苗可保护幼年恒河猴免受口服 SIV 暴露

• 批准号: 7349634
• 负责人: Marta L Marthas
• 金额: $ 15.67万
• 依托单位: UNIVERSITY OF CALIFORNIA AT DAVIS
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-05-01 至 2007-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7349634
• 关键词: SIV; VACCINES; PROTECT; INFANT; RHESUS

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Objective: Ideally, a neonatal HIV vaccine aimed to prevent HIV transmission from breastfeeding would also protect against later sexual exposure to HIV in adolescence. To test HIV vaccine candidates, we developed an infant rhesus macaque model to better mimic repeated oral HIV exposure during breast-feed

该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子弹和调查员（PI）可能已经从其他NIH来源获得了主要资金，因此可以在其他清晰的条目中代表。列出的机构适用于该中心，这不一定是调查员的机构。目的：理想情况下，旨在防止HIV传播母乳喂养的新生儿HIV疫苗也可以防止青春期后期的性暴露于HIV。为了测试HIV疫苗候选物